cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bioxcel Therapeutics
7 own
6 watching
Current Price
$0
$0.11
(0.39%)
logo-btai
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
799.22M
52-Week High
52-Week High
32.96
52-Week Low
52-Week Low
8.795
Average Volume
Average Volume
0.26M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization799.22M
icon52-Week High32.96
icon52-Week Low8.795
iconAverage Volume0.26M
iconDividend Yield--
iconP/E Ratio--
What does the Bioxcel Therapeutics do?
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent for the treatment of prostate and pancreatic cancers, and other solid tumors. BioXcel Therapeutics, Inc. has a collaboration with Merck KGaA; Nektar Therapeutics, Inc.; and Pfizer Inc. to develop a therapy for treating pancreatic cancer. The company was founded in 2017 and is headquartered in New Haven, Connecticut. BioXcel Therapeutics, Inc. is a subsidiary of BioXcel Corporation.
Read More
How much money does Bioxcel Therapeutics make?
News & Events about Bioxcel Therapeutics.
Ticker Report
6days ago
BioXcel Therapeutics, Inc. (NASDAQ:BTAI Get Rating) insider Frank Yocca sold 50,000 shares of the businesss stock in a transaction on Friday, January 20th. The stock was sold at an average price of $30.00, for a total value of $1,500,000.00. Following the transaction, the insider now ...
Zolmax
6days ago
BioXcel Therapeutics, Inc. (NASDAQ:BTAI Get Rating) insider Frank Yocca sold 50,000 shares of the businesss stock in a transaction on Friday, January 20th. The stock was sold at an average price of $30.00, for a total value of $1,500,000.00. Following the transaction, the insider now directly owns 8...
Globe Newswire
1month ago
NEW HAVEN, Conn., Dec. 22, 2022 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that Vimal Mehta, Ph.D., CEO of BioXcel ...
Ticker Report
1month ago
BioXcel Therapeutics, Inc. (NASDAQ:BTAI Get Rating) CEO Vimal Mehta sold 30,000 shares of the companys stock in a transaction that occurred on Friday, December 16th. The stock was sold at an average price of $19.44, for a total transaction of $583,200.00. Following the sale, the chief...
Zolmax
1month ago
BioXcel Therapeutics, Inc. (NASDAQ:BTAI Get Rating) CEO Vimal Mehta sold 30,000 shares of the companys stock in a transaction that occurred on Friday, December 16th. The stock was sold at an average price of $19.44, for a total transaction of $583,200.00. Following the sale, the chief executive ...
Frequently Asked Questions
Frequently Asked Questions
What is Bioxcel Therapeutics share price today?
plus_minus_icon
Can Indians buy Bioxcel Therapeutics shares?
plus_minus_icon
How can I buy Bioxcel Therapeutics shares from India?
plus_minus_icon
Can Fractional shares of Bioxcel Therapeutics be purchased?
plus_minus_icon
What are the documents required to start investing in Bioxcel Therapeutics stocks?
plus_minus_icon
What is today’s traded volume of Bioxcel Therapeutics?
plus_minus_icon
What is today’s market capitalisation of Bioxcel Therapeutics?
plus_minus_icon
What is the 52-Week High and Low Range of Bioxcel Therapeutics?
plus_minus_icon
What percentage is Bioxcel Therapeutics down from its 52-Week High?
plus_minus_icon
What percentage is Bioxcel Therapeutics up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.11
(0.39%)
logo-btai
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00